← Back to Search

Behavioural Intervention

Virtual Reality for Indigestion

N/A
Recruiting
Led By David Cangemi
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks
Awards & highlights

Summary

This trial studies the use of virtual reality to reduce stomach pain & other symptoms caused by functional dyspepsia.

Who is the study for?
This trial is for individuals with functional dyspepsia, who've had an endoscopy and been checked for H. pylori infection, which must be treated if present. They should have a history of indigestion symptoms meeting Rome IV criteria but no prior stomach surgeries or conditions like IBS as the main issue.Check my eligibility
What is being tested?
The study tests whether virtual reality can effectively treat gastrointestinal symptoms associated with functional dyspepsia. Participants will use VR technology in a controlled setting to see if it helps manage their indigestion.See study design
What are the potential side effects?
While not typical with virtual reality, some participants may experience motion sickness or discomfort due to the immersive nature of VR. These side effects are generally mild and temporary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in abdominal pain scores
Secondary outcome measures
Change in bloating
Change in heartburn
Change in nausea/vomiting
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ExperimentalExperimental Treatment1 Intervention
Experimental VR
Group II: ShamPlacebo Group1 Intervention
Sham VR
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual reality
2020
N/A
~1890

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for indigestion include proton pump inhibitors (PPIs), which reduce stomach acid production, and prokinetics, which enhance gastrointestinal motility. Additionally, treatments like cognitive-behavioral therapy (CBT) and virtual reality (VR) focus on distraction and relaxation to alleviate symptoms. These methods work by reducing stress and anxiety, which can exacerbate indigestion. For patients, understanding these mechanisms is crucial as they highlight the importance of both physiological and psychological factors in managing indigestion, offering a holistic approach to treatment.
Rumination, heartburn, and daytime gastroesophageal reflux. A case study with mechanisms defined and successfully treated with biofeedback therapy.Patient response to marketing minimally invasive surgery for heartburn.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,376 Total Patients Enrolled
David CangemiPrincipal InvestigatorMayo Clinic

Media Library

Virtual reality (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05836597 — N/A
Indigestion Research Study Groups: Experimental, Sham
Indigestion Clinical Trial 2023: Virtual reality Highlights & Side Effects. Trial Name: NCT05836597 — N/A
Virtual reality (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05836597 — N/A
~20 spots leftby Jun 2025